Phase
Condition
Rash
Hives (Urticaria)
Skin Wounds
Treatment
N/AClinical Study ID
Ages > 19 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Both gender, 19 years ≤ age
Patients with pruritus due to the following diseases
① acute eczema, chronic eczema, monetary eczema, sebaceous deficiency eczema
② contact dermatitis, atopic dermatitis, seborrheic dermatitis, neurodermatitis
③ Acute prurigo (Strofus, Urticaria, lichen urticatus), subacute prurigo, chronicprurigo (nodular prurigo)
④ systemic skin pruritus, focal skin pruritus
In visit 2, during the run-in period previous week the VAS score of day and night timewere 2 or more average points per day (maximum 4 points)
Those who can ability to record subject diary
Written consent voluntarily to participate in this clinical trial after understandingand detailed explanation about this clinical trial
Exclusion
Exclusion Criteria:
Patients with pruritus due other medical causes (liver disease, heart failure, etc.)
Among patients with skin disease, malignant tumors and patients with chronic urticariaskin disease
Patients with systemic infection symptoms at the time of clinical trials
Asthmatic patients requiring steroid treatment
Patients with Spastic diseases such as epilepsy
Study Design
Connect with a study center
Hanyang Univ. Guri Hospital
Guri-si, Kyeonggi-do 471-701
Korea, Republic ofSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.